Cargando…
A phase I (tumour site-specific) study of carboplatin and temozolomide in patients with advanced melanoma
Temozolomide is an oral alkylating agent that readily crosses the blood–brain barrier and has activity in patients with advanced melanoma. Carboplatin is a convenient outpatient treatment that also has activity in patients with melanoma. The purpose of this study was to assess the safety of a combin...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2003
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394438/ https://www.ncbi.nlm.nih.gov/pubmed/14612900 http://dx.doi.org/10.1038/sj.bjc.6601414 |